Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Biotech Alliance Creating Circular RNA Cancer Drug

Cancer on clipboard

A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug

Protein Chemistry Biotech Gains Collaboration, Venture Funds

DNA molecule model

An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds

Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization

SARS-Cov-2 virus

Findings from a clinical trial show an anti-inflammatory drug reduces new symptoms among people with Covid-19 infections and keeps them out of the hospital. . . . → Read More: Trial Shows Anti-Inflammatory Drug Stops Covid-19 Hospitalization

Company Started for Gene Editing Rare Inherited Diseases

Mitochondria illustration

A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases

Implanted Organoid Connects to Brain, Reacts to Visual Cues

Mature neuron

Engineers and neuroscientists developed a circuit that in lab mice connects implanted lab-grown brain tissue to the brain’s cognitive center and responds to visual stimuli. . . . → Read More: Implanted Organoid Connects to Brain, Reacts to Visual Cues

Over-the-Counter Naloxone Receiving Faster FDA Review

Nasal spray

The opioid overdose drug naloxone in nasal spray form is receiving priority review from the Food and Drug Administration as an over-the-counter drug. . . . → Read More: Over-the-Counter Naloxone Receiving Faster FDA Review

Peptide Discovery Company to Gain $3.3B in Licensing Deals

Test tubes in a lab

A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals

Infographic – Cancer Start-Up Venture Funds Decline

Chart: Venture funding for cancer start-ups, 2018-2022

Funding for new enterprises creating products and services that treat or detect cancer fell more than 40 percent from last year. . . . → Read More: Infographic – Cancer Start-Up Venture Funds Decline

Cell Biology Tools Companies Merge in $57.8M Deal

DNA chip graphic

Two providers of technologies for cellular analysis are merging to form a new company focusing on cell biology research tools, in a sign of continued industry consolidation. . . . → Read More: Cell Biology Tools Companies Merge in $57.8M Deal

Immune Organoid Company Raises $4.3M in Seed Funds

Microscopic image of lymph node tissue

A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds. . . . → Read More: Immune Organoid Company Raises $4.3M in Seed Funds